Dehydration removes water from fixed brain tissue before or during exposure to the nonpolar solvent environment. This changes the physical composition of the specimen and helps prepare it for lipid extraction and refractive-index matching. As a result, light scattering can decrease enough to support imaging through larger tissue volumes rather than only through thin sections.
Lipids contribute to differences in optical properties within brain tissue, which can scatter light and obscure structures located deeper in a specimen. Hydrophobic solvent treatment extracts light-scattering lipids and helps match the refractive index of the remaining components. These combined effects improve transparency, allowing distributed features such as neuronal pathways and vessels to be examined in three dimensions.
Solvent exposure does not preserve every tissue feature or label equally. The overview identifies tissue shrinkage, fluorescence loss, and limited compatibility with some molecular labels as important constraints. These effects can influence both the apparent dimensions of anatomical structures and the visibility of fluorescent signals, so transparent tissue should be interpreted with awareness of possible preparation-related changes.
The workflow uses fixed brain tissue, exposes it to nonpolar organic solvents to promote dehydration and lipid extraction, and then prepares the treated specimen for microscopy. Refractive-index matching contributes to the final optical improvement. The method therefore connects chemical processing with three-dimensional imaging, while the extent of structural and signal preservation depends on how the tissue responds to solvent exposure.
Transparent specimens can reveal anatomically distributed features across tissue volumes that are difficult to assess from isolated thin sections. In neuroscience, relevant targets include neuronal pathways and vascular networks, along with other labeled structures. This broader view can help investigators study how features are organized through the brain, provided that labeling remains detectable after solvent treatment.
Fluorescence may decline during solvent exposure, and some molecular labels may be poorly compatible with the treatment. Consequently, failure to observe a signal does not necessarily demonstrate that the corresponding structure is absent. Researchers should consider label compatibility and possible fluorescence loss when evaluating three-dimensional microscopy results, especially when comparing treated specimens with their original labeled state.